Search Results - "De Lannoy, Inés A.M."
-
1
In vivo solid-phase microextraction liquid chromatography–tandem mass spectrometry for monitoring blood eicosanoids time profile after lipopolysaccharide-induced inflammation in Sprague-Dawley rats
Published in Journal of Chromatography A (11-12-2015)“…•In vivo SPME LC–MS offers fast and non-lethal determination of blood eicosanoids.•SPME calibrated using pre-determined sampling rates.•Determination of…”
Get full text
Journal Article -
2
Pharmacokinetics
Published in Biochemical pharmacology (01-01-2014)“…Pharmacokinetics (PK) is the study of the time course of the absorption, distribution, metabolism and excretion (ADME) of a drug, compound or new chemical…”
Get full text
Journal Article -
3
The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxin
Published in Biochemical and biophysical research communications (30-11-1992)“…Digoxin, a widely used cardiac glycoside with a low therapeutic index, is known to interact with a large and diverse group of co-administered drugs, frequently…”
Get more information
Journal Article -
4
Human Amyloid-β 40 Kinetics after Intravenous and Intracerebroventricular Injections and Calcitriol Treatment in Rats In Vivo
Published in Drug metabolism and disposition (01-10-2020)“…Amyloid-β peptides of 40 and 42 amino acid lengths, which are synthesized in neurons and degraded in the brain and liver, have the potential to aggregate and…”
Get full text
Journal Article -
5
Vitamin D Receptor Activation Induces P-Glycoprotein and Increases Brain Efflux of Quinidine:An Intracerebral Microdialysis Study in Conscious Rats
Published in Pharmaceutical research (01-03-2015)“…Purpose Since the vitamin D receptor (VDR) was found to up-regulate cerebral P-glycoprotein expression in vitro and in mice, we extend our findings to rats by…”
Get full text
Journal Article -
6
Overview of pharmacokinetics
Published in Current protocols in pharmacology (02-09-2014)“…In addition to having selective potency against the molecular target(s), a compound must be able to reach its intended site of action in vivo in sufficient…”
Get more information
Journal Article -
7
Aging and brain free cholesterol concentration on amyloid‐β peptide accumulation in guinea pigs
Published in Biopharmaceutics & drug disposition (01-04-2024)“…Alzheimer’s disease is a complex multifactorial neurodegenerative disorder wherein age is a major risk factor. The appropriateness of the Hartley guinea pig…”
Get full text
Journal Article -
8
Impact of age, hypercholesterolemia, and the vitamin D receptor on brain endogenous β‐amyloid peptide accumulation in mice
Published in Biopharmaceutics & drug disposition (01-09-2021)“…Age, hypercholesterolemia, and vitamin D deficiency are risk factors that increase the brain accumulation of pathogenic β‐amyloid peptides (40 and 42),…”
Get full text
Journal Article -
9
Treatment of Porphyromonas gulae infection and downstream pathology in the aged dog by lysine‐gingipain inhibitor COR388
Published in Pharmacology research & perspectives (01-02-2020)“…COR388, a small‐molecule lysine‐gingipain inhibitor, is currently being investigated in a Phase 2/3 clinical trial for Alzheimer's disease (AD) with…”
Get full text
Journal Article -
10
Studies To Examine Potential Tolerability Differences between the 5‑HT2C Receptor Selective Agonists Lorcaserin and CP-809101
Published in ACS chemical neuroscience (17-05-2017)“…Lorcaserin (LOR) is a selective 5-HT2C receptor agonist that has been FDA approved as a treatment for obesity. The most frequently reported side-effects of LOR…”
Get full text
Journal Article -
11
Cyclosporin and quinidine inhibition of renal digoxin excretion: evidence for luminal secretion of digoxin
Published in The American journal of physiology (01-10-1992)“…We studied the in vivo luminal and contraluminal uptake of [3H]digoxin in dog kidney using the single-pass multiple indicator dilution method. A bolus tracer…”
Get full text
Journal Article -
12
Enalaprilat handling by the kidney: barrier-limited cell entry
Published in The American journal of physiology (01-11-1992)“…The angiotensin-converting enzyme inhibitor enalaprilat is formed in vivo in liver and kidney by esterolysis of the antihypertensive drug enalapril. To gain…”
Get full text
Journal Article -
13
A physiological model for renal drug metabolism: enalapril esterolysis to enalaprilat in the isolated perfused rat kidney
Published in Journal of pharmacokinetics and biopharmaceutics (01-12-1990)“…A physiologically based kidney model was developed to describe the metabolism of enalapril and explain the observed discrepancies between generated and…”
Get more information
Journal Article -
14
Formed and preformed metabolite excretion clearances in liver, a metabolite formation organ: studies on enalapril and enalaprilat in the single-pass and recirculating perfused rat liver
Published in Journal of pharmacokinetics and biopharmaceutics (01-08-1993)“…Single-pass and recirculating rat liver perfusion studies were conducted with [14C]enalapril and [3H]enalaprilat, a precursor-product pair, and the data were…”
Get more information
Journal Article -
15
Combined recirculation of the rat liver and kidney: studies with enalapril and enalaprilat
Published in Journal of pharmacokinetics and biopharmaceutics (01-08-1993)“…Combined recirculation of the rat liver (L) and kidney (IPK) at 10 ml min-1 per organ (LK) was developed to examine the hepatorenal handling of the…”
Get more information
Journal Article